Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Frontiers in Pharmacology|August 16, 2021
Expert-Augmented Computational Drug Repurposing Identified Baricitinib as a Treatment for COVID-19Daniel P Smith, Olly Oechsle, Michael J Rawling, et al.Neuropharmacology|June 17, 2018
Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's diseaseTom H Johnston, Alix M B Lacoste, Naomi P Visanji, et al.Pharmacoepidemiology and Drug Safety|May 16, 2020
Identifying drugs with disease-modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiologyLaura C Maclagan, Naomi P Visanji, Yi Cheng, et al.Pharmacoepidemiology and Drug Safety|November 21, 2020
Using artificial intelligence to identify anti-hypertensives as possible disease modifying agents in Parkinson's diseaseNaomi P Visanji, Piyush Madan, Alix M B Lacoste, et al.Plos One|April 9, 2019
Identification of pharmacodynamic biomarker hypotheses through literature analysis with IBM WatsonSonja Hatz, Scott Spangler, Andrew Bender, et al.Nature Reviews. Neurology|July 17, 2020
Applications of machine learning to diagnosis and treatment of neurodegenerative diseasesMonika A Myszczynska, Poojitha N Ojamies, Alix M B Lacoste, et al.Current Biology : CB|May 12, 2015
A convergent and essential interneuron pathway for Mauthner-cell-mediated escapesAlix M B Lacoste, David Schoppik, Drew N Robson, et al.Neuropharmacology|February 27, 2024
Using artificial intelligence to identify drugs for repurposing to treat l-DOPA-induced dyskinesiaTom H Johnston, Alix M B Lacoste, Paula Ravenscroft, et al.Nature Methods|January 19, 2016
Whole-brain activity mapping onto a zebrafish brain atlasOwen Randlett, Caroline L Wee, Eva A Naumann, et al.Nature Neuroscience|July 31, 2019
Zebrafish oxytocin neurons drive nocifensive behavior via brainstem premotor targetsCaroline L Wee, Maxim Nikitchenko, Wei-Chun Wang, et al.Pageof 1